Correlation Between Aerovate Therapeutics and SYSCO

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and SYSCO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and SYSCO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and SYSCO P 5375, you can compare the effects of market volatilities on Aerovate Therapeutics and SYSCO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of SYSCO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and SYSCO.

Diversification Opportunities for Aerovate Therapeutics and SYSCO

-0.69

Correlation Coefficient

Aerovate Therapeutics  SYSCO

Excellent diversification

The 3 months correlation between Aerovate and SYSCO is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and SYSCO P 5375 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SYSCO P 5375 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with SYSCO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SYSCO P 5375 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and SYSCO go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and SYSCO

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.23 times more return on investment than SYSCO. However, Aerovate Therapeutics is 1.23 times more volatile than SYSCO P 5375. It trades about 0.01 of its potential returns per unit of risk. SYSCO P 5375 is currently generating about -0.05 per unit of risk. If you would invest  263.00  in Aerovate Therapeutics on September 12, 2024 and sell it today you would earn a total of  0.00  from holding Aerovate Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	77.27%
Values	Daily Returns

Aerovate Therapeutics  vs.  SYSCO P 5375

Aerovate Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

SYSCO P 5375

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SYSCO P 5375 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for SYSCO P 5375 investors.

Pair Trading with Aerovate Therapeutics and SYSCO

The main advantage of trading using opposite Aerovate Therapeutics and SYSCO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, SYSCO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SYSCO will offset losses from the drop in SYSCO's long position.

The idea behind Aerovate Therapeutics and SYSCO P 5375 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.